A Safety and Tolerability Study of RJX Drug Product in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Designed as a single center, two-part, double-blind, placebo-controlled, randomized study to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of RJX in healthy participants.
Epistemonikos ID: ec8f851e7eb2e0868f1810db6283bea82642014f
First added on: Nov 30, 2020